The esophageal cancer drug pipeline analysis highlights emerging therapies targeting this aggressive malignancy with poor survival rates. With growing research into immunotherapy, targeted agents, and combination treatments, the pipeline aims to improve efficacy and outcomes, addressing the significant unmet clinical need in esophageal cancer care. https://www.expertmarketresearch.com/clinical-trials/esophageal-cancer-drug-pipeline-insight